Lithium Ion

Lithium Ion

SCHEMBL9399655

[Li+].[N+3].[OH-].[OH-].[OH-].[OH-]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL28411406 0.82
Lithium Ion SCHEMBL1714 0.82
Lithium Ion SCHEMBL26656220 0.82
Lithium Ion SCHEMBL1890966 0.82
Lithium Ion SCHEMBL8675018 0.82 CYP3A4 (0.33)
Water SCHEMBL2385745 0.82
Lithium Ion SCHEMBL28269112 0.82 CYP3A4 (0.33)
Potassium Ion SCHEMBL2747517 0.67
Ammonia Solution, Strong SCHEMBL5702304 0.67
Water SCHEMBL502820 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106795150-B 1,3,4- thiadiazole compound and its purposes in treating cancer 阿斯利康(瑞典)有限公司 2019-10-15 CN disclosed
CN-106795150-A 1,3,4 thiadiazole compounds and its purposes in treating cancer 阿斯利康(瑞典)有限公司 2017-05-31 CN disclosed
US-5331006-A Cholecystokinin, antisecretory agents WARNER-LAMBERT COMPANY (US) 1994-07-19 US disclosed
WO-1992004025-A1 AMINO ACID ANALOGS AS CCK ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1992-03-19 WO disclosed